WuXi Biologics (Cayman) Stock Forecast, Price & News

WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Frequently Asked Questions

Is WuXi Biologics (Cayman) a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for WuXi Biologics (Cayman) in the last twelve months. There are currently 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "strong buy" WuXi Biologics (Cayman) stock.
View analyst ratings for WuXi Biologics (Cayman) or view top-rated stocks.

How has WuXi Biologics (Cayman)'s stock been impacted by COVID-19?

WuXi Biologics (Cayman)'s stock was trading at $31.3225 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, WXXWY stock has decreased by 13.6% and is now trading at $27.05.
View which stocks have been most impacted by COVID-19.

Are investors shorting WuXi Biologics (Cayman)?

WuXi Biologics (Cayman) saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 113,900 shares, an increase of 574.0% from the October 31st total of 16,900 shares. Based on an average daily volume of 414,800 shares, the short-interest ratio is presently 0.3 days.
View WuXi Biologics (Cayman)'s Short Interest.

Who are WuXi Biologics (Cayman)'s key executives?

WuXi Biologics (Cayman)'s management team includes the following people:

• Dr. Ge Li, Founder & Chairman (Age 54)
• Dr. Zhisheng Chen, CEO & Exec. Director (Age 48, Pay $702.36k)
• Dr. Weichang Zhou, Exec. VP, CTO & Exec. Director (Age 57, Pay $375.99k)
• Ms. Shaohua Lu-Wong, Chief Financial Officer (Age 52)
• Dr. Jijie Gu, Exec. VP & Chief Scientific Officer (Age 55)
• Ms. Eileen Wang, IR Sr. Director
• Ms. Tang Shaogui M.B.A., VP and Head of Global Corp. Communications & Public Affairs
• Ms. Michelle M. Chen Ph.D., VP & Head of Corp. Devel.
• Mr. Jian Dong, Sr. VP of Global Biomanufacturing (Age 57)
• Mr. Angus Scott Marshall Turner, Sr. VP of Global Bus. Devel. & Alliance Management (Age 53)

Who are some of WuXi Biologics (Cayman)'s key competitors?

Some companies that are related to WuXi Biologics (Cayman) include (TNGN) (TNGN), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), ALK-Abello A/S (AKBLF), Almirall (LBTSF), Amarantus BioScience (AMBS), Amplia Therapeutics (ATX) and Anatara Lifesciences (ANR).
View all of WXXWY's competitors.

What is WuXi Biologics (Cayman)'s stock symbol?

WuXi Biologics (Cayman) trades on the OTCMKTS under the ticker symbol "WXXWY."

How do I buy shares of WuXi Biologics (Cayman)?

Shares of WXXWY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is WuXi Biologics (Cayman)'s stock price today?

One share of WXXWY stock can currently be purchased for approximately $27.05.

How many employees does WuXi Biologics (Cayman) have?

WuXi Biologics (Cayman) employs 6,646 workers across the globe.

What is WuXi Biologics (Cayman)'s official website?

The official website for WuXi Biologics (Cayman) is www.wuxibiologics.com.cn.